Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- India’s First National AVGC Centre of Excellence for Pioneering Creative Growth
- Driving Excellence in Rail: Transaction Advisory for the 100 Trainset Project
- Responsible gaming and shared responsibility: Online gaming industry in India challenges
- Need To Accelerate Climate Finance For Greening Of MSMEs In India
